These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 313108
1. Cyclophosphamide-sensitive and cyclophosphamide-resistant suppressor cells in the immune response to alloantigens. Bonavida B, Hutchinson IV, Thomas A. Transplant Proc; 1979 Mar; 11(1):874-7. PubMed ID: 313108 [Abstract] [Full Text] [Related]
2. Modulation of T-dependent cell-mediated immune responses by antigen-reactive cell opsonization and active suppression. Bonavida B, Hutchinson IV. Transplant Proc; 1978 Mar; 10(1):31-5. PubMed ID: 76350 [Abstract] [Full Text] [Related]
4. The influence of cyclophosphamide on antibody formation in the mouse. Willers JM, Sluis E. Ann Immunol (Paris); 1975 Apr; 126(3):267-79. PubMed ID: 1101799 [Abstract] [Full Text] [Related]
5. Immune mechanisms in leukemia: suppression of cellular immunity by drugs and x-irradiation. Martinez D, Lukasewycz OA, Murphy WH. J Immunol; 1975 Sep; 115(3):724-9. PubMed ID: 1151076 [Abstract] [Full Text] [Related]
6. Direct in vitro evidence for different susceptibilities to 4-hydroperoxycyclophosphamide of antigen-primed T cells regulating humoral and cell-mediated immune responses to sheep erythrocytes: a possible explanation for the inverse action of cyclophosphamide on humoral and cell-mediated immune responses. Diamantstein T, Klos M, Hahn H, Kaufmann SH. J Immunol; 1981 May; 126(5):1717-9. PubMed ID: 6452475 [Abstract] [Full Text] [Related]
7. [Immunosuppression by means of cytostatic chemotherapy. Inhibition of antibody formation and induction of tolerance in animal experiments]. Schwarze G. Fortschr Med; 1978 Nov 02; 96(41):2107-11. PubMed ID: 308923 [Abstract] [Full Text] [Related]
8. [Characteristics of cellular immunosuppression models of allotransplantation reactions]. Spasokukotskiĭ AL, Iudin VM. Eksp Onkol; 1989 Nov 02; 11(5):39-43. PubMed ID: 2529114 [Abstract] [Full Text] [Related]
9. Immune suppression in vivo with antigen-modified syngeneic cells. V. Interacting T cell subpopulations in the suppressor pathway. Sherr DH, Benacerraf B, Dorf ME. J Immunol; 1980 Oct 02; 125(4):1862-8. PubMed ID: 6997388 [Abstract] [Full Text] [Related]
10. The effect of cyclophosphamide on immunological control mechanisms. Turk JL, Parker D, Cameron AE. Int J Tissue React; 1984 Oct 02; 6(3):205-11. PubMed ID: 6480267 [Abstract] [Full Text] [Related]
11. Modulation of immune responses by suppressor T cells. Kapp JA, Pierce CW, Theze J, Benacerraf B. Fed Proc; 1978 Aug 02; 37(10):2361-64. PubMed ID: 79503 [Abstract] [Full Text] [Related]
12. Experimental Escherichia coli 06 infection in mice. II. Protective factors of immunity after immunosuppression. Ahlstedt S. Scand J Infect Dis Suppl; 1980 Aug 02; Suppl 24():216-9. PubMed ID: 7010558 [Abstract] [Full Text] [Related]
17. Potentiation of human cell-mediated and humoral immunity by low-dose cyclophosphamide. Berd D, Maguire HC, Mastrangelo MJ. Cancer Res; 1984 Nov 02; 44(11):5439-43. PubMed ID: 6488195 [Abstract] [Full Text] [Related]